DXCM

DexCom, Inc.

NasdaqGSUSDEQUITY DELAYED

92.23

▲ 2.01 (2.23%)

MARKET · —

Price

Open

90.22

Prev close

90.22

Day high

92.56

Day low

89.20

Volume

3.48M

Market cap

—

P/E (TTM)

—

52W range

54.11 – 92.56

Trailing performance

Price return · vs SPY

Returnvs SPY

+2.89% +4.3%

+31.02% +27.3%

+28.43% +25.3%

+26.35% +15.3%

YTD

+39.13% +26.8%

+13.06% -6.9%

-16.93% -91.1%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

90.00

+2.48% from price

SMA 20

85.30

+8.25% from price

SMA 50

77.63

+18.95% from price

SMA 100

71.49

+29.00% from price

SMA 200

69.32

+33.21% from price

EMA 12

88.48

+4.24% from price

EMA 26

84.24

+9.48% from price

EMA 50

79.66

+15.78% from price

RSI (14)

70.1

Overbought

MACD (12,26,9)

4.24

Hist 0.19

ATR (14)

2.57

2.79% of price

Realised vol 30D

50.2%

Annualised

Bollinger upper

97.39

20, 2σ

Bollinger lower

73.22

20, 2σ

50 / 200 cross

Golden

77.63 vs 69.32

Trend bias

Above 200

+33.21%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.72

Less volatile than market

Correlation to SPY

0.22

Largely independent

Realised vol 30D

50.2%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-33.3%

Peak to trough

Max drawdown 5Y

-66.3%

Peak to trough

ATR 14

2.57

2.79% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 92.23

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

DXCM · links out to the publisher

1 Healthcare Stock to Target This Week and 2 Facing Headwinds StockStory · 2d ago Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation? Zacks · 3d ago DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow Simply Wall St. · 4d ago DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued? Simply Wall St. · 5d ago DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates Simply Wall St. · 5d ago 1 Surging Stock Worth Your Attention and 2 We Question StockStory · 6d ago 1 Growth Stock to Stash and 2 We Brush Off StockStory · 7d ago 1 S&P 500 Stock on Our Buy List and 2 We Avoid StockStory · 8d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.